High-mix, low-volume Dorna targets lab environments requiring flexible, compact automation with high-mix, low-volume tasks, presenting an opportunity to upsell to research labs and contract testing facilities seeking scalable benchtop solutions.

Life sciences traction Trusted by Amgen and leading research institutions, Dorna’s credibility in life sciences and pharma labs can be leveraged to pursue expansion within biopharma, diagnostics, and clinical research labs that demand precise, automated sample handling and inspection.

Throughput and accuracy Position Dorna as a cost-effective path to higher throughput and reduced manual labor for repetitive lab tasks, targeting labs facing staffing constraints or high error rates in sample prep, capping/decapping, and inspection.

Desktop automation niche The desktop footprint of Dorna TA platforms suggests growth opportunities with small-to-mid sized labs, contract testing labs, and university cores seeking scalable automation without large-scale integration projects.

Growth-ready partnerships With a modest team size and global customer base, pursue partnerships with larger automation integrators, CROs, and equipment suppliers to co-market and co-sell benchtop automation workflows for sample receipt to data reporting.